BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND BTG1, P62324, 694, ENSG00000133639 AND Prognosis
28 results:

  • 1. Effect of Behavioral Health Disorders on Surgical Outcomes in cancer Patients.
    Katayama ES; Woldesenbet S; Munir MM; Endo Y; Rawicz-Pruszyński K; Khan MMM; Tsilimigras D; Dillhoff M; Cloyd J; Pawlik TM
    J Am Coll Surg; 2024 Apr; 238(4):625-633. PubMed ID: 38420963
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic nomograms for gastric carcinoma after D2 + total gastrectomy to assist decision-making for postoperative treatment: based on Lasso regression.
    Li Y; Bai M; Gao Y
    World J Surg Oncol; 2023 Jul; 21(1):207. PubMed ID: 37475024
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Total Lymph Node Yield Is Associated with Prolonged Survival after Neoadjuvant Chemotherapy in ypN0 gastric cancer Patients.
    Li W; Shao X; Ma F; Wang B; Xue L; Hu H; Kang W; Xiong J; Tian Y
    Oncol Res Treat; 2023; 46(7-8):287-295. PubMed ID: 37302386
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Noninvasive imaging of the tumor immune microenvironment correlates with response to immunotherapy in gastric cancer.
    Huang W; Jiang Y; Xiong W; Sun Z; Chen C; Yuan Q; Zhou K; Han Z; Feng H; Chen H; Liang X; Yu S; Hu Y; Yu J; Chen Y; Zhao L; Liu H; Zhou Z; Wang W; Wang W; Xu Y; Li G
    Nat Commun; 2022 Aug; 13(1):5095. PubMed ID: 36042205
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Significance of Intraperitoneal-free
    Kaku H; Aoyagi K; Sudo T; Tanaka Y; Minami T; Isobe T; Kizaki J; Umetani Y; Murakami N; Fujita F; Akagi Y
    Anticancer Res; 2022 Aug; 42(8):4003-4010. PubMed ID: 35896219
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
    Chen T; Yang C; Dou R; Xiong B
    Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]    [Full Text] [Related]  

  • 9. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
    Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
    [No Abstract]    [Full Text] [Related]  

  • 10. Value of staging information provided by linear-array endoscopic ultrasound for therapeutic response and prognosis prediction in gastric lymphoma.
    Tingyu H; Jianqiang L; Zuguang X; Xiujiang Y; Ke C
    Dig Endosc; 2021 Sep; 33(6):929-938. PubMed ID: 33124105
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for gastric cancer.
    Ge L; Zhang N; Chen Z; Song J; Wu Y; Li Z; Chen F; Wu J; Li D; Li J; Wang C; Wang H; Wang J
    Clin Chem; 2020 Feb; 66(2):342-351. PubMed ID: 32040577
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Negative lymph node count as an independent prognostic factor in stage III patients after curative gastrectomy: A retrospective cohort study based on a multicenter database.
    Zhang N; Deng J; Wang W; Sun Z; Wang Z; Xu H; Zhou Z; Liang H
    Int J Surg; 2020 Feb; 74():44-52. PubMed ID: 31874262
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinicopathological Features and prognosis of Small gastric Gastrointestinal Stromal Tumors (GISTs).
    Wang M; Xue A; Yuan W; Gao X; Fu M; Fang Y; Wang L; Shu P; Li H; Hou Y; Shen K; Sun Y; Qin X
    J Gastrointest Surg; 2019 Nov; 23(11):2136-2143. PubMed ID: 31012047
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical usefulness of gastric adenocarcinoma predictive long intergenic noncoding RNA in human malignancies: A meta-analysis.
    Liu W; Xu J; Zhang C
    Pathol Res Pract; 2019 Jun; 215(6):152387. PubMed ID: 30904361
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.
    Liu K; Feng F; Chen XZ; Zhou XY; Zhang JY; Chen XL; Zhang WH; Yang K; Zhang B; Zhang HW; Zhou ZG; Hu JK
    Gastric Cancer; 2019 May; 22(3):506-517. PubMed ID: 30390154
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Positive expression of chemokine (C-C Motif) ligand 18 and prognosis in cancer: A meta-analysis.
    Huang H; Li J; Hu WJ; Chen MH; Chen SS; Chen C; Luo HQ; Zhou KY; Liu XG; Li XY
    J BUON; 2018; 23(4):1185-1194. PubMed ID: 30358230
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node-Positive gastric cancer Treated with Different Adjuvant Protocols.
    Yu JI; Lim DH; Lee J; Kang WK; Park SH; Park JO; Park YS; Lim HY; Kim ST; Lee SJ; Kim S; Sohn TS; Lee JH; An JY; Choi MG; Bae JM; Yoo H; Kim K
    Cancer Res Treat; 2019 Jul; 51(3):876-885. PubMed ID: 30282450
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment.
    Kim SY; Yoon MJ; Park YI; Kim MJ; Nam BH; Park SR
    Gastric Cancer; 2018 May; 21(3):453-463. PubMed ID: 28828688
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Predictive Role of the Number of 18F-FDG-Positive Lymph Nodes Detected by PET/CT for Pre-Treatment Evaluation of Locally Advanced gastric cancer.
    Wang X; Wei Y; Xue Y; Lu P; Yu L; Shen B
    PLoS One; 2016; 11(12):e0166836. PubMed ID: 27936109
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer.
    Jin C; Shi W; Wang F; Shen X; Qi J; Cong H; Yuan J; Shi L; Zhu B; Luo X; Zhang Y; Ju S
    Oncotarget; 2016 Aug; 7(32):51763-51772. PubMed ID: 27322075
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.